Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27344205.
- Also identified by DOI 10.1016/j.kint.2016.03.042 and PMC identifier 5679458.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lupus nephritis is a common and severe manifestation of systemic lupus erythematosus that disproportionately affects nonwhites and those in lower socioeconomic groups. This review discusses recent data on the incidence, prevalence, and outcomes of patients with lupus nephritis with a focus on low-income US Medicaid patients. We also review recent guidelines on diagnosis, treatment, and screening for new onset and relapses of lupus nephritis. Finally, we discuss the management of lupus nephritis from a rheumatologist's perspective, including vigilance for the common adverse events related to disease and treatment, and we review prevention and new treatment strategies.
Medical subject headings
- Glucocorticoids
- Health Services Accessibility
- Immunosuppressive Agents
- Lupus Nephritis